DeLiver Pharma ApS: Financial statements 2024
CVR: 39432714
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
DeLiver Pharma ApS (CVR 39432714) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -10,302 and a net result of DKK -21,682 compared with DKK 107,283 the year before. Equity in the 2024 report amounted to DKK 195,088. The solvency ratio was 94.7%.
- Gross Profit
- DKK -10,302
- Profit/Loss
- DKK -21,682
- Equity
- DKK 195,088
- Total Assets
- DKK 206,088
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -10K | -22K | 195K | 0 |
| 2023 | - | 119K | 107K | 217K | 0 |
| 2022 | - | -18K | -29K | 109K | - |
| 2021 | - | -22K | -147K | 139K | - |
| 2020 | - | -20K | -114K | 246K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
DeLiver Pharma ApS has published its annual report for 2023. Gross profit came to DKK 118,663, and the net result was DKK 107,283.
About DeLiver Pharma ApS
DeLiver Pharma ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Niels Jonas Heilskov Graversen. The board consists of Jens Kristian Damsgaard (chair), Holger Jon Møller, Niels Jonas Heilskov Graversen and Søren Kragh Moestrup. The company's owners include MOESTRUP HOLDING 2007 ApS, MØLLER HOLDING 2007 ApS and PHIDEAS ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -20,487 and a net result of DKK -31,867 compared with DKK -21,682 the year before. Equity in the 2025 report amounted to DKK 163,221.